Effectiveness of a tailored web app on sun protection intentions and its implications for skin cancer prevention: A randomized controlled trial

PLOS Digit Health. 2022 May 12;1(5):e0000032. doi: 10.1371/journal.pdig.0000032. eCollection 2022 May.

Abstract

Skin cancers related to sunexposure are rising globally, yet largely preventable. Digital solutions enable individually tailored prevention and may play a crucial role in reducing disease burden. We developed SUNsitive, a theory-guided web app to facilitate sun protection and skin cancer prevention. The app collected relevant information through a questionnaire and provided tailored feedback on personal risk, adequate sun protection, skin cancer prevention, and overall skin health. SUNsitive's effect on sun protection intentions and a set of secondary outcomes was evaluated with a two-arm randomized controlled trial (n = 244). At 2 weeks post-intervention, we did not find any statistical evidence for the intervention's effect on the primary outcome or any of the secondary outcomes. However, both groups reported improved intentions to sun protect compared to their baseline values. Furthermore, our process outcomes suggest that approaching sun protection and skin cancer prevention with a digital tailored "questionnaire-feedback" format is feasible, well-perceived, and well accepted. Trial registration: Protocol registration: ISRCTN registry (ISRCTN10581468).

Grants and funding

The project was partially funded by the University of Zurich Digital Science Initiative (funding received by MP and VN). The funder had no role in the design or implementation of the study.